Prophylaxis for venous thrombo-embolism in neurocritical care: A critical appraisal

Neurocritical Care

Volumn 12, Issue 2, 2010, Pages 297-309

  Raslan, Ahmed M ^a,b   Fields, Jeremy D ^a,b   Bhardwaj, Anish ^a,b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Compression stockings; Deep vein thrombosis; Heparin; Intermittent compression devices; Venous thromboembolism

Indexed keywords

ACENOCOUMAROL; ARDEPARIN; ARGATROBAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; BRODIFACOUM; DALTEPARIN; DANAPAROID; ENOXAPARIN; FONDAPARINUX; HEPARIN; HEPARINOID; IDRAPARINUX; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PHENINDIONE; PHENPROCOUMON; PLACEBO; REVIPARIN; TINZAPARIN; WARFARIN;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN TUMOR; CANCER INCIDENCE; COMPRESSION GARMENT; CRITICALLY ILL PATIENT; HUMAN; INFERIOR CAVA VEIN; INTERMETHOD COMPARISON; INTRAPARENCHYMAL HEMORRHAGE; NEUROLOGIC DISEASE; NEUROSURGERY; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

BRAIN ISCHEMIA; BRAIN NEOPLASMS; CRITICAL CARE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; NEUROSURGICAL PROCEDURES; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 77953614494     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-009-9316-7     Document Type: Review

References (94)

1. Kearon C, Ginsberg J, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolisn. Ann Intern Med. 1998;129:1044-1049
2. Wells P, Lensing A, Davidson B, et al. Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery: a meta-analysis. Ann Intern Med. 1995;122:47-53.
3. Pierce C, Haut E, Kardooni S, et al. Surveillance bias and deep venous thrombosis in the national trauma data bank: the more we look, the more we find. J Trauma. 2008;64:932-937
4. Piotrowski JJ, Alexander JJ, Brandt CP, McHenry CR, Yuhas JP, Jacobs D. Is deep vein thrombosis surveillance warranted in high risk trauma patients? Am J Surg. 1996;172:210-213
5. Velmahos GC, Nigro J, Tatevossian R, et al. Inability of an aggressive policy of thromboprophylaxsis to prevent deep vein thrombosis (DVT) in critically injured patients: are current methods of DVT prophylaxis insufficient? J Am Coll Surg. 1998; 187:529-533
6. Cipolle MD, Wojcik R, Seislove E, Wasser TE, Pasquale MD. The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J Trauma. 2002;52:453-462
7. Misra M, Roitberg B, Ebersole K, Charbel F. Prevention of pulmonary embolism by combined modalities of thromboprophylaxis and intensive surveillance protocol. Neurosurgery. 2004; 54:1099-1102
8. Geerts W, Heit J, Clagett P, et al. Prevention of venous thromboembolism. Chest. 2001;119:132S-175S. (Pubitemid 32162075)
9. Hirsh J, Dalen J, Anderson D, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119:8S-21S.
10. Hirsh J, Warkentin T, Shauhnessy S, et al. Heparin and low-molecular-weight heparin mechanisms ofaction, pharmacokinetics, dosing, monitoring, efficacy and safety. Chest. 2001;119:64S-94S.
11. Weitz J, Hirsh J. New anticoagulant drugs. Chest. 2001;119:95S- 107S. (Pubitemid 32154196)
12. Fleming T. Red book: pharmacy's fundamental reference (Red Book Drug Topics), 111 ed. Montvale, NJ: Thomson Healthcare; 2007.
13. Micromedex ® Healthcare Series: www.micromedex.com,2009.
14. Crowther MA, Cook DJ. Thrombophrophylaxis in medical-surgical critically ill patients. Curr Opin Crit Care. 2008;14:520-523
15. Limpus A, Chaboyer W, McDonald E, et al. Mechanical thrombophrophylaxis in critically ill patients: a systematic review and meta-analysis. Am J Crit Care. 2006;15:402-410
16. Agnelli G, Piovella F, Buincristiani P, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med. 1998;339:80-85
17. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:338S-400S.
18. Greets WH, Bergvist D, Pineo GF, et al. Prevention of venous thromboembolism. American College of Chest Physicians Evidence Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:381S-453S.
19. Committee for Standards in Hematology: Writing Group: Baglin TP, Brush J, Streiff M. Guidelines on use of vena cava filters. Br J Haematol. 2006; 134: 590-595
20. McMurtry AL, et al. Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of PE. J Am Coll Surg. 1995;189(3):314-320
21. Karmy-Jones R, Jurkovich GJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients: an AAST multi-center study. J Trauma. 2007;62:17-24.
22. Marras LC, Greets WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma. Cancer. 2000;89:640-646
23. Chiocca EA, Schwartzbaum JA. Gliomas and venous thromboembolism: how common? Editor J Neurosurg. 2007;106:599-600.
24. Brandes AA, Scelzi E, Salmistraro E, et al. Incidence and risk of thromboembolism during treatment of high-grade gliomas: a prospective study. Eur J Cancer. 1997;33:1592-1596
25. Semrad TJ, O'Donnell R, Wun T, et al. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg. 2007;106:601-608
26. Turpie AG, Hirsh J, Gent M, et al. Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. Arch Intern Med. 1989;149:679-681
27. Bucci MN, Papadopoulos SM, Chen JC, et al. Mechanical prophylaxis of venous thrombosis in patients undergoing craniotomy: a randomized trial. Surg Neurol. 1989;32:285-288
28. Wautrecht JC, Macquaire V, Vandesteene A, et al. Prevention of deep vein thrombosis in neurosurgical patients with brain tumors: a controlled, randomized study comparing graded compression stockings alone and with intermittent sequential compression. Correlation with pre- and postoperative fibrinolysis. Preliminary results. Int Angiol. 1996;15(3 Suppl 1):5-10.
29. Dickinson L, Miller L, Patel C, et al. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery. 1998;43:1074-1079 (Pubitemid 28481108)
30. Carmen T, Kanner A, Barnett G, et al. Prevention of thromboembolism after neurosurgery for brain and spinal tumors. South Med J. 2003;96:17-22.
31. Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neuro-surgery: a meta-analysis. Arch Intern Med. 2000;160:2327-2332
32. Constantini S, Kornowski R, Pomeranz S, et al. Thromboembolic phenomena in neurosurgical patients operated upon for primary and metastatic brain tumors. Acta Neurochir (Wien). 1991;109 (3-4):93-97
33. Goldhaber S, Dunn K, Gerhard-Herman M, et al. Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest. 2002;122:1933-1937
34. McCarthy ST, Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Ageing. 1986;15:84-88
35. McCarthy ST, Turner JJ, Robertson D, et al. Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet. 1977;310:800-901.
36. Kelly J, Rudd A, Lewis R, et al. Venous thromboembolism after acute stroke. Stroke. 2001;32:262-267
37. Prasad BK, Banerjee AK, Howard H. Incidence of deep vein thrombosis and the effect of pneumatic compression of the calf in elderly hemiplegics. Age Ageing. 1982;11:42-44
38. Muir KW, Watt A, Baxter G, et al. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. Q J Med. 2000;93:359-364
39. The CLOTS Trials Collaboration. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep venous thrombosis after stroke (CLOTS trial 1): a multicentre, randomized controlled trial. Lancet. 2009;373:1958-1965
40. Gubitz G, Sandercock P, Counsell C. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2004;3: CD00 0024.
41. Hillbom M, Erila T, Sotaniemi K, et al. Enoxaparin vs. heparin for prevention of deep-vein thrombosis in acute ischemic stroke: a randomized, double-blind study. Acta Neurol Scand. 2002;106: 84-92.
42. Diener HC, Ringelstein E, Kummer RV, et al. Prophylaxis of thrombotic and embolic events in acute ischemic stroke with low-molecular weight heparin certoparin. Results of the PROTECT trial. Stroke. 2006;37:139-214
43. Sherman D, Albers G, Bladin C, et al. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischemic stroke (PREVAIL Study): an open label randomized comparison. Lancet. 2007;369:1347-1355
44. Gould MK, Dembitzer AD, Doyle RL, et al. Low molecular weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: a meta-analysis of randomized, controlled trials. Ann Intern Med. 1999;130:800-809
45. Adams H, Adams R, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the stroke council of the American stroke association. Stroke. 2003;34:1056-1083
46. Adams HP, et al. AHA/ASA guidelines for the early management of adults with ischemic stroke. Stroke. 2007;38:1655-1711
47. Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):630S-69S.
48. Gregory PC, Kuhlemeier KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil. 2003;82:384-389
49. Skaf E, Stein P, Beemath A, et al. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Card. 2005; 96:1731-1733
50. Goldstein JN, Fazen LE, Wendell L, et al. Risk of thromboembolism following acute intracerebral hemorrhage. Neurocrit Care. 2009;10:28-34.
51. Lacut K, Bressollette L, Le Gal G, et al. Prevention of venous thrombosis in patients with acute intracereberal hemorrhage. Neurology. 2005;65:865-869 (Pubitemid 41362131)
52. Tetri S, Hakala J, Juvela S, et al. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage. Thromb Res. 2008;123(2): 206-212
53. Boeer A, Voth E, Henze T, et al. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1991;54:466-467
54. Dickmann U, Voth E, Schicha H, et al. Heparin therapy, deepvein thrombosis and pulmonary embolism after intracerebral hemorrhage. Klin Wochenschr. 1988;66:1182-1183
55. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/ American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38: 2001-2023
56. Bertram M, Bonsanto M, Hacke W, et al. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol. 2000;247: 209-214
57. Streiff MB. Vena caval filters: a comprehensive review. Blood. 2000;95:3669-3677
58. Sironen J, Juvela S, Varis J, et al. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg. 2003; 99:953-959
59. Collen JF, Jackson JL, Shorr AF, Moores LK. Prevention of venous thromboembolism in neurosurgery: a metaanalysis. Chest. 2008;134:237-319
60. Browd SR, Ragel BT, Davis GE, et al. Prophylaxis for deep venous thrombosis in neurosurgery: a review of the literature. Neurosurg Focus. 2004;17(4):E1.
61. Danish S, Burnett M, Ong J, et al. Prophylaxis for deep venous thrombosis in craniotomy patients: a decision analysis. Neurosurgery. 2005;56:1286-1294
62. Jacobs DG, Piotrowski JJ, HoppensteadtDA, etal. Hemodynamicand fibrinolytic consequences of intermittent pneumaticcompression: preliminary results. J Trauma. 1996;40: 710-717
63. Ting A, Cheng S, Cheung G, et al. Perioperative deep vein thrombosis in Chinese patients undergoing craniotomy. Surg Neurol. 2002;58:274-279
64. Stephens PH, Healy MT, Smith M, et al. Prophylaxis against thromboembolism in neurosurgical patients: a survey of current practice in the United Kingdom. Br J Neurosurg. 1995;9:159-163
65. Nurmohamed MT, van Riel AM, Henkens CM, et al. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost. 1996;75:233-238
66. Kurtoglu M, Yanar H, Bilsel Y, et al. Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin. World J Surg. 2004;28:807-811
67. Cerrato D, Ariano C, Fiacchino F. Deep vein thrombosis and low dose heparin prophylaxis in neurosurgical patients. J Neurosurg. 1978;49:378-381
68. Goldhaber SZ, Dunn K, Gerhard-Herman M, et al. Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest. 2002;122(6):1933-1937
69. Macdonald RL, Amidei C, Baron J, et al. Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surg Neurol. 2003;59:363-72. discussion 372-374
70. Prestar FJ. Prevention of thromboembolism complications with low molecular weight heparin in microneurosurgical lumbar intervertebral disk operations. Neurochirurgia (Stuttg). 1992;35: 1-4.
71. Voth D, Schwarz M, Hahn K, et al. Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen. Neurosurg Rev. 1992; 15:289-294
72. Knudson MM, Ikossi DG, Khaw L, et al. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg. 2004;240:490-6. discussion 496-498
73. Knudson MM, Lewis FR, Clinton A, et al. Prevention of venous thromboembolism in trauma patients. J Trauma. 1994;37:480-487
74. Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996;335:701-707
75. Attia J, Ray JG, Cook DJ, et al. Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med. 2001;161: 1268-1279
76. Gerlach R, Scheuer T, Beck J, et al. Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. Neurosurgery. 2003;53: 1028-34. discussion 1034-1035
77. Kleindienst A, Harvey H, Mater E, et al. Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Acta Neurochir (Wien). 2003;145:1085-1091
78. Norwood SH, McAuley CE, Berne JD, et al. Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg. 2002;137:696-701. discussion 701-702
79. Kim J, Gearhart MM, Zurick A, et al. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma. 2002;53:38-112
80. Cothren CC, Smith WR, Moore EE, Morgan SJ. Utility of once daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients. World J Surg. 2007;31:98-104.
81. Vergouwen MD, Roos YB, Kamphuisen PW. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury. Curr Opin Crit Care. 2008;14: 149-155
82. Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. V. Deep vein thrombosis prophylaxis. J Neurotrauma. 2007;24 Suppl 1:S32-6.
83. Yao JST. Deep vein thrombosis in spinal cord-injured patients: evaluation and assessment. Chest. 1992;102(suppl):645S-8S.
84. Geerts WH, Code KI, Jay RM, et al. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331: 1601-1606
85. Gunduz S, Ogur E, Mohur H, et al. Deep vein thrombosis in spinal cord injured patients. Paraplegia. 1993;31:606-610
86. Waring WP, Karunas RS. Acute spinal cord injuries and the incidence of clinically occurring thromboembolic. Paraplegia. 1991;29:8-16.
87. Kim SW, Charalles JT, Park KW, et al. Prevalence of deep vein thrombosis in patients with chronic spinal cord injury. Arch Physical Med Rehabil. 1994;75:965-968
88. Jones T, Ugalde V, Franks P, et al. Venous thromboembolism after spinal cord injury: incidence, time course, and associated risk factors in 16,240 adults and children. Arch Phys Med Rehabil. 2005;86:2240-2247
89. Spinal Cord Medicine Consortium. Clinical practice guidelines. J Spinal Cord Med. 1998;21:248-293
90. Wade W, Chisholm M. Venous thrombosis after acute spinal cord injury. Am J Phys Med Rehabil. 2000;97:504-508
91. Deep K, Jigajinni MV, McLean A, Fraser M. Prophylaxis of thromboembolism in spinal injuries-results of enoxaparin used in276 patients. Spinal Cord. 2001;39:88-91.
92. Thumikat P, Poonnoose P, Balasubrahmaniam P, et al. A comparison of heparin/warfarin and enoxaparin thromboprophylaxis in spinal cord injury: the Sheffield experience. Spinal Cord. 2002;40:416-420
93. Slavik R, Chan E, Gorman S, et al. Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial. J Trauma. 2007;62:1075-1081
94. Maxwell RA, Chavarria-Aguilar M, Cockerham WT, et al. Routine prophylactic vena cava filtration is not indicated after acute spinal cord injury. J Trauma. 2002;52:902-906